Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inka Wiegratz

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Therapeutische Umschau. Revue Therapeutique|September 24, 2021
[MHT: How and how long in healthy women above 65?]Inka Wiegratz
Drugs|October 16, 2004
Long-cycle treatment with oral contraceptivesInka Wiegratz, Herbert Kuhl
Treatments in Endocrinology|April 19, 2005
Managing cutaneous manifestations of hyperandrogenic disorders: the role of oral contraceptivesInka Wiegratz, Herbert Kuhl
Trends in Endocrinology and Metabolism: TEM|September 11, 2004
Progestogen therapies: differences in clinical effects?Inka Wiegratz, Herbert Kuhl
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|October 24, 2006
Metabolic and clinical effects of progestogensInka Wiegratz, Herbert Kuhl
Deutsches Arzteblatt International|August 5, 2011
Hormonal contraception--what kind, when, and for whom?Inka Wiegratz, Christian J Thaler
Menopause (New York, N.Y.)|June 26, 2002
Formation of 7 alpha-methyl-ethinyl estradiol during treatment with tiboloneInka Wiegratz, Nicole Sänger, Herbert Kuhl
Women'S Health (London, England)|October 7, 2009
Extended and continuous use of hormonal contraceptives to reduce menstruationInka Wiegratz, Stefan Kissler, Herbert Kuhl, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|May 3, 2014
Effect of a low-dose contraceptive patch on efficacy, bleeding pattern, and safety: a 1-year, multicenter, open-label, uncontrolled studyInka Wiegratz, Susana Bassol, Edith Weisberg, et al.
Fertility and Sterility|October 2, 2007
Umbilical endometriosis in pregnancy without previous surgeryInka Wiegratz, Stefan Kissler, Knut Engels, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Therapeutische Umschau. Revue Therapeutique|September 24, 2021
[MHT: How and how long in healthy women above 65?]Inka Wiegratz
Drugs|October 16, 2004
Long-cycle treatment with oral contraceptivesInka Wiegratz, Herbert Kuhl
Treatments in Endocrinology|April 19, 2005
Managing cutaneous manifestations of hyperandrogenic disorders: the role of oral contraceptivesInka Wiegratz, Herbert Kuhl
Trends in Endocrinology and Metabolism: TEM|September 11, 2004
Progestogen therapies: differences in clinical effects?Inka Wiegratz, Herbert Kuhl
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|October 24, 2006
Metabolic and clinical effects of progestogensInka Wiegratz, Herbert Kuhl
Deutsches Arzteblatt International|August 5, 2011
Hormonal contraception--what kind, when, and for whom?Inka Wiegratz, Christian J Thaler
Menopause (New York, N.Y.)|June 26, 2002
Formation of 7 alpha-methyl-ethinyl estradiol during treatment with tiboloneInka Wiegratz, Nicole Sänger, Herbert Kuhl
Women'S Health (London, England)|October 7, 2009
Extended and continuous use of hormonal contraceptives to reduce menstruationInka Wiegratz, Stefan Kissler, Herbert Kuhl, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|May 3, 2014
Effect of a low-dose contraceptive patch on efficacy, bleeding pattern, and safety: a 1-year, multicenter, open-label, uncontrolled studyInka Wiegratz, Susana Bassol, Edith Weisberg, et al.
Fertility and Sterility|October 2, 2007
Umbilical endometriosis in pregnancy without previous surgeryInka Wiegratz, Stefan Kissler, Knut Engels, et al.
Pageof 3